Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Treat-to-Target Decisions and Dilemmas

David S. Pisetsky, MD, PhD  |  Issue: July 2011  |  July 12, 2011

As it turns out, the house officer was right. There were in fact some joints with synovitis (three metacarpophalangeal joints to be precise), and the tissues surrounding the joints were clearly thickened. When I pressed these joints bit harder, Mr. Jones said, “I can feel it,” which I interpreted as mild tenderness. Not surprisingly, the global assessment was low and, like some stoics and people who want to banish symptoms with positive thought, Mr. Jones rated it only a 10 on a 0 to 100 scale.

Given the physical findings, I expected a DAS in the 3 to 4 range and was prepared to recommend a boost in the methotrexate dose. The difficulty, however, was the erythrocyte sedimentation rate (ESR). The ESR was 1 and, even if the patient had synovitis in up to 10 joints (with a global of 10), an ESR that low produces a DAS in the remission range. I therefore had to ask myself which number was more informative: the joint count or the ESR rate?

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

T2T is here to stay, even if an occasional value … will stymie me as I decide whether to increase or decrease an agent or add another therapy. Rheumatologists have an increasingly large armamentarium of effective agents to allow target practice (pun intended).

Making the Right Decision?

As Ted Pincus has pointed out, many people with putatively active RA have a normal ESR, especially when adjusted for age and gender. However, the observation begs the question of whether, in the range of values we consider normal, there are important physiological or pathophysiological differences that could affect the course of RA and the likelihood for joint damage. Thus, ESR values of 1 and 30 are both “normal,” but a value of 30 may indicate the presence of proteins in the blood that reflect mischief in the joints. Such proteins could fuel inflammation just as they coat red cells to make them propel down a thin tube under the watchful eye of a laboratory technician.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

In view of the discrepancy between the clinical and laboratory findings, perhaps Mr. Jones’ disease was inactive, with the ESR of 1 a bona fide measure of the quiescence of his immune system. The swelling that both the house officer and I felt could be fibrosis, indicating a process of healing or repair of past inflammation, a time of nastier events when the synovium teemed with angry macrophages, T cells, and fibroblasts. In this scenario, the tenderness could represent the aftermath of damage. Maybe in RA, joints with erosion are chronically tender, just as joints with osteoarthritis—pock marked with cysts and encrusted with spurs—are tender even if the synovium in osteoarthritis shows only a scant smattering of synovial cells.

Page: 1 2 3 4 | Single Page
Share: 

Filed under:Education & TrainingOpinionRheuminationsSpeak Out Rheum Tagged with:Diagnosispatient carerheumatologistTreat-to-Target

Related Articles

    Strong Support for Treat-to-Target Strategy in RA Patients

    March 16, 2020

    NEW YORK (Reuters Health)—In daily clinical practice, following a treat-to-target (T2T) strategy in patients with rheumatoid arthritis (RA) leads to higher rates of remission compared with not following a T2T strategy, according to a longitudinal analysis of real world data. “The results of the analysis provide direct evidence that following T2T, and particularly sustained T2T,…

    Twenty Questions, Part 1

    February 1, 2007

    What disease scores can teach you about rheumatology

    Readers Answer ‘Twenty Questions’

    April 1, 2007

    The March Rheuminations column, “Twenty Questions, Part 1” inspired many letters from TR readers. Here are just a few of those responses.

    Treat to Target in axSpA

    November 29, 2022

    PHILADELPHIA—Treat to target (T2T) is a common phrase in rheumatology these days—and a welcome one.1 Many of us are familiar with what T2T means in rheumatoid arthritis (RA), but we may be less sure of its meaning in axial spondyloarthritis (axSpA). At ACR Convergence 2022, Alexis Ogdie, MD, associate professor of medicine and epidemiology, University of…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences